Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Total Liabilities
Based on the latest financial reports, Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) has total liabilities worth €204.50 Million EUR (≈ $239.09 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Eckert & Ziegler Strahlen- und Medizintechnik AG - Total Liabilities Trend (2013–2025)
This chart illustrates how Eckert & Ziegler Strahlen- und Medizintechnik AG's total liabilities have evolved over time, based on quarterly financial data. See EUZ net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Eckert & Ziegler Strahlen- und Medizintechnik AG Competitors by Total Liabilities
The table below lists competitors of Eckert & Ziegler Strahlen- und Medizintechnik AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Suzhou Sunmun Technology Co Ltd
SHE:300522
|
China | CN¥257.24 Million |
|
Sipef NV
BR:SIP
|
Belgium | €167.17 Million |
|
Aeva Technologies, Inc. Common Stock
NYSE:AEVA
|
USA | $45.74 Million |
|
Guangdong Banbao Toy Co Ltd
SHG:603398
|
China | CN¥2.73 Billion |
|
Xinjiang Baodi Mining Co. Ltd. A
SHG:601121
|
China | CN¥4.05 Billion |
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.18 Billion |
|
Hongbo Co Ltd
SHE:002229
|
China | CN¥1.07 Billion |
|
Shanghai Huitong Energy Co Ltd
SHG:600605
|
China | CN¥91.03 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Eckert & Ziegler Strahlen- und Medizintechnik AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Eckert & Ziegler Strahlen- und Medizinte market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eckert & Ziegler Strahlen- und Medizintechnik AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eckert & Ziegler Strahlen- und Medizintechnik AG (2013–2025)
The table below shows the annual total liabilities of Eckert & Ziegler Strahlen- und Medizintechnik AG from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €204.50 Million ≈ $239.09 Million |
-5.84% |
| 2024-12-31 | €217.18 Million ≈ $253.91 Million |
+0.89% |
| 2023-12-31 | €215.27 Million ≈ $251.67 Million |
+5.94% |
| 2022-12-31 | €203.21 Million ≈ $237.57 Million |
+30.93% |
| 2021-12-31 | €155.20 Million ≈ $181.45 Million |
+8.47% |
| 2020-12-31 | €143.08 Million ≈ $167.28 Million |
+6.15% |
| 2019-12-31 | €134.79 Million ≈ $157.59 Million |
+28.16% |
| 2018-12-31 | €105.17 Million ≈ $122.96 Million |
+5.73% |
| 2017-12-31 | €99.47 Million ≈ $116.29 Million |
+11.28% |
| 2016-12-31 | €89.39 Million ≈ $104.50 Million |
-2.85% |
| 2015-12-31 | €92.01 Million ≈ $107.57 Million |
-0.90% |
| 2014-12-31 | €92.84 Million ≈ $108.54 Million |
+5.33% |
| 2013-12-31 | €88.14 Million ≈ $103.05 Million |
-- |
About Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories… Read more